Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging

Description

This is a two-tiered pilot study in which there will be no randomization and no placebo treatment. This study will be to perform metabolic magnetic resonance imaging on men suspected to have a prostate cancer to understand if metabolic MRI can be safely performed on this population

Conditions

Prostate Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

This is a two-tiered pilot study in which there will be no randomization and no placebo treatment. This study will be to perform metabolic magnetic resonance imaging on men suspected to have a prostate cancer to understand if metabolic MRI can be safely performed on this population

Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging in the Diagnosis and Risk-Stratification of Prostate Cancer

Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging

Condition
Prostate Cancer
Intervention / Treatment

-

Contacts and Locations

Baltimore

University of Maryland Medical Center, Baltimore, Maryland, United States, 21201

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Age greater than 40 and less than 80 years
  • 2. Clinical suspicion or history of prostate cancer reflected by one of the following:
  • * PSA \> 4ng/ml
  • * Abnormal DRE exam
  • * Known tissue diagnosis of prostate cancer from prior workup
  • 3. Patient planning to undergo either a MRI targeted biopsy or radical prostatectomy for prostate cancer workup or treatment
  • 1. Inability to undergo MRI scan
  • 2. Inability to receive IV contrast as per institutional protocol.

Ages Eligible for Study

40 Years to 80 Years

Sexes Eligible for Study

MALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Maryland, Baltimore,

Study Record Dates

2027-12-31